My Watchlist

Top Indices

SPX

My Portfolio

iRhythm Technologies, Inc. - Common Stock (NQ:IRTC)

170.82 +2.32 (+1.38%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iRhythm Technologies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Earnings Preview For iRhythm Technologies ↗

October 29, 2024

Via Benzinga

Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy

October 28, 2024

From iRhythm

Via GlobeNewswire

Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio? ↗

October 27, 2024

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?

Via Benzinga

Topics Government

IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC

October 25, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Beyond The Numbers: 9 Analysts Discuss iRhythm Technologies Stock ↗

October 14, 2024

Via Benzinga

Key Takeaways From iRhythm Technologies Analyst Ratings ↗

September 25, 2024

Via Benzinga

Nasdaq Turns Higher; Verizon Shares Fall After Q3 Results ↗

October 22, 2024

Via Benzinga

With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says ↗

October 22, 2024

FDA approves iRhythm's 510(k) submission for Zio AT device. A second approval may come soon, enhancing the company's mobile cardiac telemetry services.

Via Benzinga

Crude Oil Rises Sharply; 3M Posts Upbeat Earnings ↗

October 22, 2024

Via Benzinga

Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday ↗

October 22, 2024

Via Benzinga

Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

October 22, 2024

Via Benzinga

Expert Ratings For iRhythm Technologies ↗

August 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 21, 2024

Via Benzinga

iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device

October 21, 2024

Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients

From iRhythm

Via GlobeNewswire

iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024

October 16, 2024

From iRhythm

Via GlobeNewswire

4 Analysts Assess iRhythm Technologies: What You Need To Know ↗

August 02, 2024

Via Benzinga

IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC

September 30, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence

September 11, 2024

From iRhythm

Via GlobeNewswire

iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting

September 09, 2024

From iRhythm

Via GlobeNewswire

iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring

September 04, 2024

iRhythm granted exclusive license to BioIntelliSense’s patented pulse oximetry, accelerometry and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring (ACM)...

From iRhythm

Via GlobeNewswire

iRhythm Technologies Announces Results of GUARD-AF Trial

September 01, 2024

From iRhythm

Via GlobeNewswire

Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday ↗

August 29, 2024

Via Benzinga

iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain

August 29, 2024

From iRhythm

Via GlobeNewswire

iRhythm Technologies to Participate in Upcoming Investor Conferences in September

August 21, 2024

From iRhythm

Via GlobeNewswire

IRTC Stock Earnings: iRhythm Technologies Beats EPS, Beats Revenue for Q2 2024 ↗

August 01, 2024

IRTC stock results show that iRhythm Technologies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

iRhythm Technologies Announces Chief Financial Officer Transition

August 01, 2024

From iRhythm

Via GlobeNewswire

iRhythm Technologies Announces Second Quarter 2024 Financial Results

August 01, 2024

From iRhythm

Via GlobeNewswire

7 Leading MedTech Stocks for Next-Gen Health Solutions ↗

July 31, 2024

With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.

Via InvestorPlace

7 Robotics Stocks That Could Grow Your Wealth ↗

July 22, 2024

Explore robotics stocks with the potential to grow investors' wealth as the industry expands across various sectors.

Via InvestorPlace

3 Healthcare Stocks to Buy Now: Q3 Edition ↗

July 21, 2024

U.S. healthcare expenditures will grow by 5.6% annually, presenting a revenue tailwind for these healthcare stocks to buy now.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.